Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals
暂无分享,去创建一个
D. Levy | E. Benjamin | R. Vasan | Thomas J. Wang | M. Larson | M. Keyes | D. Levy
[1] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[2] M. Drazner,et al. Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study , 2005, Circulation.
[3] F. Crampes,et al. An Unsuspected Metabolic Role for Atrial Natriuretic Peptides: The Control of Lipolysis, Lipid Mobilization, and Systemic Nonesterified Fatty Acids Levels in Humans , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[4] T. Jørgensen,et al. N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome , 2005, Hypertension.
[5] Jan Frystyk,et al. Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.
[6] Richard Kahn,et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.
[7] J. Jordan,et al. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. , 2005, The Journal of clinical endocrinology and metabolism.
[8] G. Leoncini,et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients , 2005, Journal of internal medicine.
[9] D. Lloyd‐Jones,et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. , 2005, American heart journal.
[10] N. Moustaid‐Moussa,et al. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. , 2005, Diabetes.
[11] H. Ueshima,et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? , 2005, Journal of Human Hypertension.
[12] R. Krauss,et al. Diagnosis and management of the metabolic syndrome , 2005 .
[13] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[14] A. Quyyumi,et al. Renin-Angiotensin System and Angiotensin Receptor Blockers in the Metabolic Syndrome , 2004, Circulation.
[15] D. Fliser,et al. Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation , 2004, Circulation.
[16] P. Savage,et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. , 2004, Diabetes.
[17] E. Frohlich,et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. , 2004, Journal of the American College of Cardiology.
[18] D. Levy,et al. Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.
[19] D Ghigo,et al. Insulin Stimulates Glucose Transport Via Nitric Oxide/Cyclic GMP Pathway in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[20] A. Vollmar,et al. ANP inhibits TNF‐α‐induced endothelial MCP‐1 expression—involvement of p38 MAPK and MKP‐1 , 2003 .
[21] D. Levy,et al. Heritability and Genetic Linkage of Plasma Natriuretic Peptide Levels , 2003, Circulation.
[22] S. Jacob,et al. Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance , 2003, Diabetes, obesity & metabolism.
[23] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[24] A. Vollmar,et al. ANP inhibits TNF-alpha-induced endothelial MCP-1 expression--involvement of p38 MAPK and MKP-1. , 2003, Journal of leukocyte biology.
[25] D. Levy,et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. , 2002, The American journal of cardiology.
[26] Arya M. Sharma,et al. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. , 2002, Diabetes.
[27] A. Vollmar,et al. Inhibition of cyclooxygenase-2 by natriuretic peptides. , 2002, Endocrinology.
[28] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[29] M. Berlan,et al. Natriuretic peptides: a new lipolytic pathway in human adipocytes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] A. Vollmar,et al. cGMP-Mediated Inhibition of TNF-α Production by the Atrial Natriuretic Peptide in Murine Macrophages1 , 2000, The Journal of Immunology.
[31] E. Bonora,et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.
[32] E. Gabazza,et al. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. , 1999, The Journal of clinical endocrinology and metabolism.
[33] B. Balkau,et al. Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[34] G. Leese,et al. Atrial natriuretic peptide in Type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[35] C. Berne,et al. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats , 1998, Diabetologia.
[36] R. Sarzani,et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients , 1997, Journal of Hypertension.
[37] Ralph B D'Agostino,et al. Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.
[38] E. Verspohl,et al. Atrial natriuretic peptide (ANP)-induced inhibition of glucagon secretion: Mechanism of action in isolated rat pancreatic islets , 1996, Peptides.
[39] C. Kahn,et al. Cross-talk between the insulin and angiotensin signaling systems. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[41] O. Smithies,et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension , 1995, Science.
[42] N. Markandu,et al. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. , 1993, Journal of human hypertension.
[43] C. Johnston,et al. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. , 1989, The American journal of medicine.
[44] J. Laragh,et al. Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. , 1989, Clinical science.
[45] P. Weidmann,et al. Increase in Circulating Insulin Induced by Atrial Natriuretic Peptide in Normal Humans , 1986, Journal of cardiovascular pharmacology.
[46] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[47] A. Shore,et al. RAISED CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDES IN ESSENTIAL HYPERTENSION , 1986, The Lancet.
[48] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[49] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.
[50] J. Tobin. Estimation of Relationships for Limited Dependent Variables , 1958 .